Equity Research Report: Star Health & Allied Insurance Company Ltd.
Date: January 28, 2026
Current Market Price (CMP): ₹440.00 (NSE) / ₹426.00 (BSE/Other Source)
Market Cap: ₹25,765 Cr (Approx)
Sector: Insurance (General – Standalone Health)
1️⃣ Business Model & Work
Company Overview:
Star Health India ki pehli aur sabse badi Standalone Health Insurance (SAHI) company hai. Ye company sirf health, personal accident, aur overseas travel insurance provide karti hai. Unlike general insurers (jo car, fire, marine bhi karte hain), inka 100% focus health par hai.
Revenue Source:
- Retail Health: ~85-90% (Dominant source). Company ka main focus individual agents ke through retail policies bechna hai.
- Group Health (Corporate): ~10-15%.
- Personal Accident/Travel: <2%.
Key Competitive Advantage (Moat):
- Agency Network: India ka sabse bada health insurance agent network (8 Lakh+ agents).
- Network Hospitals: 14,000+ hospitals jahan cashless facility available hai.
- Specialized Products: Diabetes, Cardiac care, aur Cancer patients ke liye specific products jo competitors easily nahi offer karte.
2️⃣ Industry & Sector Analysis
- Status: India ka Health Insurance sector Secular Growth phase me hai (long-term uptrend). India me healthcare inflation (14-15%) aur awareness badhne se insurance ab ‘luxury’ nahi ‘necessity’ ban gaya hai.
- Growth Drivers:
- Regulatory Support: IRDAI ka “Insurance for All by 2047” vision.
- Medical Inflation: Rising hospital costs logon ko higher sum insured lene par majboor kar rahe hain.
- Competition:
- Direct Competitors (SAHI): Care Health, Niva Bupa.
- General Insurers: ICICI Lombard, Bajaj Allianz, New India Assurance (ye bhi health policies bechte hain).
3️⃣ Latest Financial Performance (STRICT DATA)
⚠️ DATA SOURCE DIFFERENCE OBSERVED:
- CMP: NSE reports ₹440, while some aggregator sources show ₹426. Analysis is based on ₹440 level.
- Q3 FY26 Update: Latest quarter (Dec 2025) me company ne massive turnaround report kiya hai.
| Metric | FY 2023 (Audited) | FY 2024 (Audited) | FY 2025 (Est/Trend) | Q3 FY26 (Latest) |
| Gross Written Premium (GWP) | ₹12,952 Cr | ₹15,251 Cr | ₹16,849 Cr (TTM) | ₹5,047 Cr |
| Net Profit (PAT) | ₹619 Cr | ₹845 Cr | ₹646 Cr (Dip) | ₹449 Cr |
| Combined Ratio | ~95.3% | ~96.7% | 100%+ (Bad) | 98.9% (Improved) |
| Claims Ratio | ~65% | ~66.5% | ~70-71% | 68.8% |
| Solvency Ratio | 2.14x | 2.2x | 2.2x | Stable |
Observation:
- Turnaround: FY25 me profitability gir gayi thi (High claims), lekin Q3 FY26 me profit 4x jump hokar ₹449 Cr ho gaya hai.
- Claims Control: Claims ratio wapas <69% range me aa gaya hai jo ek healthy sign hai.
4️⃣ Management & Shareholding (Latest Available)
- Promoters: 58.02% (Stable). Rakesh Jhunjhunwala family (Rekha Jhunjhunwala) backed hai. Promoter selling ka koi major recent panic nahi hai.
- FIIs (Foreign Investors): 13.50% (Slightly Reduced from ~17% in previous quarters).
- DIIs (Mutual Funds): ~21.00% (Increased significantly). Domestic funds ne stake badhaya hai, jo long-term confidence dikhata hai.
- Governance: Recent times me AHPI (Association of Healthcare Providers) ke sath conflict hua tha regarding cashless services, jo ab stabilize ho raha hai.
5️⃣ Valuation (Latest Market Data)
- Current P/E Ratio: ~49x (Due to earnings recovery).
- Price to Book (P/B): ~3.4x.
- Peer Comparison:
- ICICI Lombard: P/B ~6-7x (Premium valuation due to diversified book).
- Star Health: P/B ~3.4x (Discount par trade kar raha hai due to recent struggles).
Fair Value Approach:
- Insurance companies ko P/B (Price to Book) par value kiya jata hai. Current 3.4x valuation historical average (5-6x) se kafi neeche hai. Agar Q3 FY26 jaisa performance continue raha, to re-rating possible hai.
6️⃣ Future Growth Triggers (3–5 Years)
- Premium Hike: Company ne recently premiums increase kiye hain (pricing discipline), jiska asar margins par dikhne laga hai.
- Rural Push: Government ki schemes aur new regulatory changes ke karan Tier-2/3 cities se volume growth aayegi.
- Digital Sales: Q3 FY26 me 76% premium collection digital channels se aaya hai, jo operational cost kam karega.
7️⃣ Present Situation (Current Outlook)
- Short-Term: Bullish. Q3 FY26 ke strong results (Profit up 414%) ne market sentiment badal diya hai. Stock apne 52-week low se recover kar raha hai.
- Long-Term: Cautiously Optimistic. Company “Claims Ratio” ko control karne me successful dikh rahi hai. Agar ye 66-68% range me maintain rehta hai, to stock wapas purane highs touch kar sakta hai.
8️⃣ Risk & Red Flags
- Regulatory Risk: IRDAI ke rules (jaise surrender charges, claim settlement speed) margins par pressure daal sakte hain.
- Hospital Conflicts: Hospitals ke saath tariff (rates) ko lekar jhagde (AHPI notice Sept 2025) ek bada risk hai. Agar hospitals cashless deny karte hain to business hurt hoga.
- Competition: Niva Bupa aur Care Health aggressively market share cheen rahe hain.
9️⃣ Final Verdict
- Summary: Star Health ek strong franchise hai jo pichle 1-2 saal se “Profitability Issue” face kar rahi thi. Q3 FY26 ke results confirm karte hain ki turnaround shuru ho chuka hai.
- Conservative Investor: Wait karein. Dekhein ki kya company ye low claims ratio (68%) agle quarter bhi maintain kar paati hai.
- Aggressive Investor: Current levels (₹440) par accumulate kar sakte hain. Risk-Reward favorable hai kyunki valuation depressed hai.
- Target Range (1 Year): ₹520 – ₹550 (Assumes P/B rerating to 4x).
- Stop Loss: ₹380 (Weekly closing basis).
Disclaimer: Ye article sirf educational purpose ke liye hai. Kisi bhi nivesh se pehle apne Financial Advisor se salah zarur lein.